Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two-particle correlations at small relative momenta for 40Ar-induced reactions on 197Au at E/A=60 MeV.
Pochodzalla J, Gelbke CK, Lynch WG, Maier M, Ardouin D, Delagrange H, Doubre H, Grégoire C, Kyanowski A, Mittig W, Péghaire A, Péter J, Saint-Laurent F, Zwieglinski B, Bizard G, Lefèbvres F, Tamain B, Québert J, Viyogi YP, Friedman WA, Boal DH. Pochodzalla J, et al. Among authors: doubre h. Phys Rev C Nucl Phys. 1987 May;35(5):1695-1719. doi: 10.1103/physrevc.35.1695. Phys Rev C Nucl Phys. 1987. PMID: 9953958 No abstract available.
Inclusive two-particle correlations for 16O-induced reactions on 197Au at E/A=94 MeV.
Chen Z, Gelbke CK, Gong WG, Kim YD, Lynch WG, Maier MR, Pochodzalla J, Tsang MB, Saint-Laurent F, Ardouin D, Delagrange H, Doubre H, Kasagi J, Kyanowski A, Péghaire A, Péter J, Rosato E, Bizard G, Lefèbvres F, Tamain B, Québert J, Viyogi YP. Chen Z, et al. Among authors: doubre h. Phys Rev C Nucl Phys. 1987 Dec;36(6):2297-2308. doi: 10.1103/physrevc.36.2297. Phys Rev C Nucl Phys. 1987. PMID: 9954352 No abstract available.
Nuclear temperatures and the population of particle-unstable states of 6Li in 40Ar-induced reactions on 197Au at E/A=60 MeV.
Pochodzalla J, Friedman WA, Gelbke CK, Lynch WG, Maier M, Ardouin D, Delagrange H, Doubre H, Grégoire C, Kyanowski A, Mittig W, Péghaire A, Péter J, Saint-Laurent F, Viyogi YP, Zwieglinski B, Bizard G, Lefèbvres F, Tamain B, Québert J. Pochodzalla J, et al. Among authors: doubre h. Phys Rev Lett. 1985 Jul 8;55(2):177-180. doi: 10.1103/PhysRevLett.55.177. Phys Rev Lett. 1985. PMID: 10032021 No abstract available.
gamma rays from peripheral and central collisions in the reaction 40Ar+158Gd at 44 MeV/nucleon.
Hingmann R, Kühn W, Metag V V, Mühlhans R, Novotny R, Ruckelshausen A, Cassing W, Emling H, Kulessa R, Wollersheim HJ, Hass B, Vivien JP, Boullay A, Delagrange H, Doubre H, Grégoire C, Schutz Y. Hingmann R, et al. Among authors: doubre h. Phys Rev Lett. 1987 Feb 23;58(8):759-762. doi: 10.1103/PhysRevLett.58.759. Phys Rev Lett. 1987. PMID: 10035029 No abstract available.
Nucleus-nucleus potential inside the strong-absorption radius from 16O.
Roussel P, Alamanos N, Auger F, Barrette J, Berthier B, Fernandez B, Papineau aL, Doubre H, Mittig W. Roussel P, et al. Among authors: doubre h. Phys Rev Lett. 1985 Apr 22;54(16):1779-1782. doi: 10.1103/PhysRevLett.54.1779. Phys Rev Lett. 1985. PMID: 10031138 No abstract available.
Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08-2015 ENERGY): a randomised, open-label, phase 3 study.
Léna H, Greillier L, Cropet C, Bylicki O, Monnet I, Audigier-Valette C, Falchero L, Vergnenègre A, Demontrond P, Geier M, Guisier F, Hominal S, Locher C, Corre R, Chouaid C, Ricordel C; GFPC 08–2015 ENERGY investigators. Léna H, et al. Lancet Respir Med. 2024 Oct 29:S2213-2600(24)00264-9. doi: 10.1016/S2213-2600(24)00264-9. Online ahead of print. Lancet Respir Med. 2024. PMID: 39486424
A prospective analysis of the management practices for patients with Stage-III-N2Non-Small-Cell lung cancer (OBSERVE IIIA-B GFPC 04-2020Study).
Jacob M, Fournel P, Tissot C, Cadranel J, Bylicki O, Monnet I, Justeau G, Ricordel C, Thomas P, Falchero L, Locher C, Wislez M, Vergnenegre A, Abdiche S, Guisier F, Bizieux A, Lamy R, François G, De Chabot G, Pierret T, Sabatini M, Abeillera M, Vieillot S, Martinez S, Morel H, Doubre H, Madroszyk A, Geier M, LucLabourey J, Chouaïd C, Greillier L. Jacob M, et al. Among authors: doubre h. Lung Cancer. 2024 Aug;194:107868. doi: 10.1016/j.lungcan.2024.107868. Epub 2024 Jul 11. Lung Cancer. 2024. PMID: 39003937 Free article.
Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study).
Dhamelincourt E, Descourt R, Rousseau-Bussac G, Doubre H, Decroisette C, Demontrond P, Le Garff G, Falchero L, Huchot E, Vieillot S, Corre R, Kazulinski L, Bizieux A, Bigay-Gamé L, Morel H, Molinier O, Chouaïd C, Guisier F. Dhamelincourt E, et al. Among authors: doubre h. Target Oncol. 2023 Nov;18(6):905-914. doi: 10.1007/s11523-023-01014-z. Epub 2023 Nov 15. Target Oncol. 2023. PMID: 37966566
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study).
Decroisette C, Greillier L, Curcio H, Pérol M, Ricordel C, Auliac JB, Falchero L, Veillon R, Vieillot S, Guisier F, Marcq M, Justeau G, Bigay-Game L, Bernardi M, Doubre H, Pinsolle J, Amrane K, Chouaïd C, Descourt R. Decroisette C, et al. Among authors: doubre h. J Immunother. 2023 Oct 9. doi: 10.1097/CJI.0000000000000490. Online ahead of print. J Immunother. 2023. PMID: 37807621
42 results